TA
NVIV

Teachers Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Teachers Advisors’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3
Closed -$213K – 3220
2017
Q1 		$213K Hold
3
– – ﹤0.01% 2864
2016
Q4 		$221K Buy
3
+1
+50% +$89.4K ﹤0.01% 2881
2016
Q3 		$284K Hold
2
– – ﹤0.01% 2735
2016
Q2 		$258K Hold
2
– – ﹤0.01% 2763
2016
Q1 		$269K Hold
2
– – ﹤0.01% 2669
2015
Q4 		$277K Hold
2
– – ﹤0.01% 2740
2015
Q3 		$332K Hold
2
– – ﹤0.01% 2635
2015
Q2 		$622K Buy
+2
New +$529K ﹤0.01% 2396

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Teachers Advisors's NVIV Position: Q2 2017 in Review

Teachers Advisors sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2017, closing a stake of 3 shares — an estimated $213K sold.

Teachers Advisors first reported a position in NVIV in Q2 2015 and held it in 8 quarters. The position peaked at $622K in Q2 2015. 37 funds tracked by Wall St. Rank hold NVIV as of Q2 2017.

  • Teachers Advisors reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2017 after selling out during the quarter.
  • Teachers Advisors sold 3 InVivo Therapeutics Holdings Corp shares in Q2 2017, an estimated $213K.
  • Teachers Advisors first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and held it in 8 quarters.
  • Teachers Advisors's InVivo Therapeutics Holdings Corp position peaked at $622K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2017.

Based on Teachers Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.